Radboudumc ( Site 1504) — Nijmegen, Gelderland

Public research footprint of Radboudumc ( Site 1504), compiled from the ClinicalTrials.gov public registry.

469

Registered studies

181

Active

105

Recruiting now

168

Completed

Stopped or withdrawn

Most-studied conditions

Ulcerative Colitis · Non-small Cell Lung Cancer · Endometrial Cancer · Relapsed or Refractory Multiple Myeloma (RRMM)

Recently updated registry entries

NCT07554339 — A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell… (Recruiting)
NCT06997497 — A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People… (Recruiting)
NCT07742735 — A Study to Investigate the Efficacy and Safety of Apraglutide Compared With Placebo in… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Radboudumc ( Site 1504)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.